Get the Daily Brief
Latest Biotech News
Novel Immunotherapies and Regulatory Approvals in Cancer and Autoimmune Diseases
Recent data highlights significant progress in novel therapeutic agents. Sanofi secured FDA approval for rilzabrutinib, its BTK inhibitor, advancing its immunology portfolio targeting rare...
Emerging Protein and RNA Technologies Propel Therapeutic Innovation
Cutting-edge research is advancing protein and RNA-based therapeutics. Raina Biosciences unveiled GEMORNA, a generative AI platform that designs mRNA sequences with enhanced stability and...
Breakthroughs in Neuroscience and Neurodegenerative Disease Research
Recent investigations offer new insights into neurodegeneration and brain health. Adaptive deep brain stimulation (aDBS) demonstrates improved outcomes for Parkinson’s disease motor symptoms. The...
Oncology Insights: Cancer Metabolism, Biomarkers, and Metastasis
Groundbreaking studies clarify mechanisms of cancer progression and therapeutic resistance. Research reveals branched-chain amino acids fuel tumor growth, while a long non-coding RNA network...
Biotech Funding Surges Amid Strategic Collaborations and AI Integration
The biotech sector experiences robust capital influx and partnerships bolstering innovation. Patient Square Capital closed over $3 billion for its second fund, emphasizing healthcare investment....
Organ Transplant and Immunotherapy Innovations
Cutting-edge cellular therapies are redefining transplant and cancer treatment modalities. UCLA researchers engineered AlloCAR70-NKT, an off-the-shelf immunotherapy targeting metastatic kidney...
Regulatory and Market Developments in Biopharma Sector
Recent regulatory and market activities underscore pivotal shifts in the biotech industry. The FDA approved a subcutaneous formulation of Eisai and Biogen’s Alzheimer’s drug Leqembi, intensifying...
FDA Approves Sanofi BTK Inhibitor Rilzabrutinib for Immune Thrombocytopenia
The FDA granted approval to Sanofi's BTK inhibitor, rilzabrutinib, marking a critical expansion in Sanofi's immunology portfolio. Acquired through the $3.7 billion purchase of Principia Biopharma,...
Zephyr AI Augments Cancer Data Assets via Aster Insights Acquisition
Zephyr AI, a developer of AI-driven platforms for personalized cancer medicine, has expanded its real-world oncology data resources through the acquisition of Aster Insights. This move grants...
UCLA Develops Off-the-Shelf CAR-NKT Immunotherapy Targeting Metastatic Kidney Cancer
Researchers at UCLA have engineered AlloCAR70-NKT cells, an off-the-shelf immunotherapy harnessing engineered natural killer T cells to target CD70-expressing metastatic renal cell carcinoma. This...
Revolutionary AI Method MIGHT Enhances Early Cancer Detection Test Accuracy
Johns Hopkins University researchers introduced MIGHT, a novel AI framework for cancer screening enhancing sensitivity at a high specificity target of 98%. By employing multidimensional informed...
Novo Nordisk Partners with Replicate Bioscience to Accelerate RNA Therapeutics Pipeline
Novo Nordisk and Replicate Bioscience entered a strategic collaboration leveraging Replicate’s self-replicating RNA (srRNA) platform to develop novel therapeutics for obesity, type 2 diabetes, and...
Pioneering Pig-to-Human Lung Transplant Survives Nine Days Without Immediate Rejection
Scientists at Guangzhou Medical University accomplished the first successful transplantation of a genetically modified pig lung into a brain-dead human recipient, maintaining lung function for...
Machine Learning Integrates Radiomic and Clinical Data for Hodgkin Lymphoma Treatment Prediction
Innovative studies employ PET/CT radiomics combined with clinical features to predict treatment response in Hodgkin lymphoma patients. These methodologies, leveraging advanced imaging biomarkers...
Advancements in Kidney Transplantation Through Single-Cell and Genomic Analyses
Cutting-edge single-cell sequencing and spatial transcriptomics technologies are transforming kidney transplantation research by elucidating intricate cellular dynamics within grafts. Studies...
Cleveland Clinic Adopts Dyania Health AI to Accelerate Clinical Trial Recruitment
Cleveland Clinic is expanding its use of Dyania Health’s artificial intelligence platform to streamline the clinical trial enrollment process. The system rapidly analyzes electronic health records...
Regulatory Shifts and Leadership Changes Shake U.S. Biotech and Public Health Agencies
Significant regulatory developments include the FDA approval of Eisai-Biogen’s subcutaneous Leqembi formulation and the recent resignations of three CDC leaders amid policy disagreements with the...
Single-dose RSV vaccine halves hospitalizations in elderly for two seasons
A robust multicenter study led by the IVY Network demonstrates that a single shot of the respiratory syncytial virus (RSV) vaccine provides significant protection against severe RSV illness and...
Alnylam's hypertension drug gagal shows mixed trial results
Alnylam Pharmaceuticals reported that its RNAi therapeutic zilebesiran failed to significantly reduce blood pressure in a pivotal Phase 2 study, casting uncertainty on the drug’s benefit as it...
Novo Nordisk and Replicate partner on self-replicating RNA for metabolic diseases
Novo Nordisk has entered a $550 million multi-year collaboration with Replicate Bioscience to develop novel therapeutics targeting obesity, type 2 diabetes, and cardiometabolic conditions using...